Table 2.
Comparing the laboratory parameters of the COVID-19 patients at the time of admission between survived and non-survived
| Characteristics |
Total
(n=921) |
Survived
(n=745) |
Non-Survived
(n=176) |
P |
|---|---|---|---|---|
| White blood cells, ×10 9 /ml | 7.096± 4.279 | 6.964 ± 4.089 | 7.656±5.010 | 0.125 |
| Lymphocytes, ×10 9 /ml | 1.59±0.91 | 1.71 ± 0.88 | 1.09 ± 0.87 | <0.001 |
| Hemoglobin, g/L | 13.41±2.13 | 13.03 ±1.86 | 15.00 ± 2.46 | <0.001 |
| Platelets, ×10 9 /ml | 182.6 ±81.8 | 183.2±82.5 | 179.8±79.5 | 0.721 |
| PaO 2, mmHg | 45.60±23.03 | 46.60±23.70 | 41.48±19.72 | 0.012 |
| PH | 7.32±0.10 | 7.31 ±0.09 | 7.37±0.10 | <0.001 |
| PaCO2 | 41.50±12.10 | 41.72±11.69 | 40.61±13.71 | 0.260 |
| HCO3 | 21.29±4.85 | 21.29±4.79 | 21.27±5.12 | 0.803 |
| ALT, U/L | 44.45±27.31 | 45.20 ±27.17 | 41.33 ±27.91 | 0.352 |
| AST, U/L | 55.16±23.38 | 54.26±22.97 | 58.79±24.81 | 0.185 |
| BUN, mmol/L | 20.13±12.69 | 19.74±12.38 | 21.79±13.95 | 0.476 |
| Creatinine, umol/L | 1.59±1.44 | 1.59±1.17 | 1.61±0.98 | 0.973 |
| Potassium, mmol/L | 4.68±1.23 | 4.69±1.32 | 4.64±0.79 | 0.985 |
| Sodium, mmol/L | 137.14±7.86 | 137.26±8.35 | 136.65±5.47 | 0.130 |
| Ferritin, | 528.1±380.2 | 519.3±391.0 | 579.5±311.8 | 0.235 |
| d-Dimer | 910.5±841.0 | 881.5±851.7 | 1018.6±798.2 | <0.001 |
| Blood sugar | 130.28±57.26 | 127.59±59.71 | 141.50±44.38 | <0.001 |
| Creatine kinase | 308.1±411.3 | 303.9±405.6 | 326.9±440.1 | 0.929 |
| Lactate Dehydrogenase | 672.6±310.0 | 646.5±280.4 | 776.9±393.3 | 0.019 |
| C-reactive protein | 68.15±44.11 | 67.88±44.85 | 69.28±41.23 | 0.880 |
| ESR | 48.87±25.94 | 49.20±25.56 | 47.54±23.41 | 0.696 |
Data are presented as mean ± standard deviation (SD). ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; BUN: Blood Urea Nitrogen; ESR: erythrocyte sedimentation rate.